Exact Mass: 484.2104
Exact Mass Matches: 484.2104
Found 206 metabolites which its exact mass value is equals to given mass value 484.2104
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Corlan
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Methyl 6,6-bis[4-methoxy-3-(methoxycarbonyl)-5-methylphenyl]hex-5-enoate
(2S)-2-(Benzenesulfonamido)-N-[(1S)-1-hydroxy-3-methyl-1-(3-oxo-2-phenylcyclopropen-1-yl)butan-2-yl]-4-methylpentanamide
1,7-dihydroxy-1-methyl-4-(4-hydroxy-2-oxo-pentyl)-6-(6-methylocta-2,4-dienoyl)-2-oxo-1,2-dihydronaphthalene-8-carboxylic acid methyl ester|sassafrin D
Verrucarin J
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
17-defurano-17-(2xi-2,5-dihydro-2-hydroxy-5-oxofuran-3-yl)-28-deoxonimbolide|methyl (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cS)-8-[(2xi)-2,5-dihydro-2-hydroxy-5-oxofuran-3-yl]-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-5-oxo-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-bc]difuran-6-acetate
2-O-Methyl-physodsaeure|2-O-Methylphysodic Acid|2-O-Methylphysodsaeure|3-hydroxy-8-methoxy-11-oxo-1-(2-oxo-heptyl)-6-pentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid|8-O-Methylphysodic acid
C27H32O8_(1R,3R,8R,12E,18E,20Z,24R,25S)-5,13,25-Trimethyl-11H,17H,22H-spiro[oxirane-2,26-[2,10,16,23]tetraoxatetracyclo[22.2.1.0~3,8~.0~8,25~]heptacosa[4,12,18,20]tetraene]-11,17,22-trione
His Met Pro Thr
His Met Thr Pro
His Asn Asn Thr
His Asn Gln Ser
His Asn Ser Gln
His Asn Thr Asn
His Pro Met Thr
His Pro Thr Met
His Gln Asn Ser
His Gln Ser Asn
His Ser Asn Gln
His Ser Gln Asn
His Thr Met Pro
His Thr Asn Asn
His Thr Pro Met
Met His Pro Thr
Met His Thr Pro
Met Pro His Thr
Met Pro Thr His
Met Thr His Pro
Met Thr Pro His
Asn His Asn Thr
Asn His Gln Ser
Asn His Ser Gln
Asn His Thr Asn
Asn Asn His Thr
Asn Asn Thr His
Asn Gln His Ser
Asn Gln Ser His
Asn Ser His Gln
Asn Ser Gln His
Asn Thr His Asn
Asn Thr Asn His
Pro His Met Thr
Pro His Thr Met
Pro Met His Thr
Pro Met Thr His
Pro Thr His Met
Pro Thr Met His
Gln His Asn Ser
Gln His Ser Asn
Gln Asn His Ser
Gln Asn Ser His
Gln Ser His Asn
Gln Ser Asn His
Ser His Asn Gln
Ser His Gln Asn
Ser Asn His Gln
Ser Asn Gln His
Ser Gln His Asn
Ser Gln Asn His
Thr His Met Pro
Thr His Asn Asn
Thr His Pro Met
Thr Met His Pro
Thr Met Pro His
Thr Asn His Asn
Thr Asn Asn His
Thr Pro His Met
Thr Pro Met His
Thr Thr Thr Tyr
Thr Thr Tyr Thr
Thr Tyr Thr Thr
Tyr Thr Thr Thr
Oxirane, 2,2-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-, homopolymer, di-2-propenoate
hydrogen bis[benzene-o-diolato(2-)-O,O]borate(1-), compound with N,N-di-o-tolylguanidine (1:1)
(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] diacrylate
S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate
Methyl 2-[6-(furan-3-yl)-14-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7,18-dioxapentacyclo[11.3.1.111,14.02,11.05,10]octadec-9-en-16-yl]acetate
S-[2-({n-[(2r)-2-Hydroxy-3,3-Dimethyl-4-(Phosphonooxy)butanoyl]-Beta-Alanyl}amino)ethyl] Octanethioate
[4-(2-Pyridinyl)-1-piperazinyl]-[2-(3,4,5-trimethoxyphenyl)-4-quinolinyl]methanone
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-7-[(E)-2-phenylethenyl]-1-(pyridine-3-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-12-acetyl-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
(1S,9R,10R,11R)-12-acetyl-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-10-(hydroxymethyl)-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-(2-phenylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylpropanamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-7-[(E)-2-phenylethenyl]-1-(pyridine-3-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1R,3R,8R,24R,25S,26S)-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,12,18,20-tetraene-26,2-oxirane]-11,17,22-trione
(1R,3R,8R,20Z,24R,25S,26S)-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,12,18,20-tetraene-26,2-oxirane]-11,17,22-trione
S-octanoyl-4-phosphopantetheine
An S-acyl-4-phosphopantetheine obtained by formal condensation of the thiol group of D-pantetheine 4-phosphate with the carboxy group of octanoic acid.
LM22B-10
LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor, and can induce TrkB, TrkC, AKT and ERK activation in vitro and in vivo.
methyl (8s)-2,8-dihydroxy-5-[(4s)-4-hydroxy-2-oxopentyl]-8-methyl-3-[(2e,4e,6r)-6-methylocta-2,4-dienoyl]-7-oxonaphthalene-1-carboxylate
methyl 3-[11-(furan-3-yl)-3-hydroxy-2,6,10-trimethyl-4,13-dioxo-5-(propan-2-ylidene)-12,15-dioxatetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan-6-yl]prop-2-enoate
11'-hydroxy-2,2,2',6',9',12'-hexamethyl-15'-methylidene-6,10',14'-trioxo-13'-oxaspiro[pyran-3,5'-tetracyclo[7.5.1.0¹,¹¹.0²,⁷]pentadecan]-6'-en-8'-yl acetate
methyl 2-[(1s,2s,4r,6r,9r,10r,11r,15r,18r)-6-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-7,9,11,15-tetramethyl-14-oxo-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadeca-7,12-dien-10-yl]acetate
methyl 2-[(1s,2r,5r,6r,13s,17s)-6-(furan-3-yl)-1,5,16,16-tetramethyl-8,14,18-trioxo-7,15-dioxatetracyclo[11.4.1.0²,¹¹.0⁵,¹⁰]octadec-10-en-17-yl]acetate
methyl 2-[6-(furan-3-yl)-10-hydroxy-1,7,11,13,13-pentamethyl-4,14-dioxo-5,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,15-dien-12-yl]acetate
(1r,12r,15s,23r)-16-acetyl-1-hydroxy-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione
8,10-dihydroxy-9-(1-hydroxy-2-methylbut-3-en-2-yl)-2,5,5-trimethyl-7,12-dioxo-1,2,3,4,4a,12b-hexahydro-6-oxatetraphen-3-yl acetate
methyl 2-[6-(furan-3-yl)-1,5,16,16-tetramethyl-8,14,18-trioxo-7,15-dioxatetracyclo[11.4.1.0²,¹¹.0⁵,¹⁰]octadec-10-en-17-yl]acetate
(1r,2r,4s,6s,7s,8r,10s,11s,12r,14s,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-phenyl-16-(prop-1-en-2-yl)-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadecan-5-one
(2s,3'r,8'r,12'e,18'e,20'z,24'r,25's)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
16-acetyl-24-hydroxy-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione
10,15-dihydroxy-6,14,18,18,22-pentamethyl-8,19-dioxo-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11,20-tetraen-5-yl acetate
atalantolide
{"Ingredient_id": "HBIN017267","Ingredient_name": "atalantolide","Alias": "NA","Ingredient_formula": "C27H32O8","Ingredient_Smile": "CC(=C1C(=O)C(C2(C(C1(C)C=CC(=O)OC)CCC3(C24C(O4)C(=O)OC3C5=COC=C5)C)C)O)C","Ingredient_weight": "484.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1957","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101281328","DrugBank_id": "NA"}